Category: Laser/Light-based DevicesSyndicate content

Biolase launches $12M private placement amid internal turmoil, shares soar

July 21, 2014 by Arezu Sarvestani

Wall Street rallies as dental laser maker Biolase raises $12 million through a private placement round, even as the company deals with an ongoing civil war involving ousted CEO Federico Pignatelli.

Biolase launches $12M private placement

California-based Biolase (NSDQ:BIOL) announced today that it secured $12 million in a private placement funding round, even as the company weathers the internal tumult following the ouster of former CEO Federico Pignatelli.

Ex-Biolase CEO isn't giving up without a fight

June 27, 2014 by Arezu Sarvestani

Ousted Biolase CEO Federico Pignatelli launches an investigation into the device maker, saying he suspects "wrongdoing, mismanagement and corporate governance failures."

Ex-Biolase CEO isn't giving up without a fight

Shares of Biolase (NSDQ:BIOL) got a modest boost today, even as a company insider announced a far-reaching investigation into the company's management under the suspicion of wrongdoing.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

CEO Pignatelli out after court-ordered shake-up at Biolase

June 17, 2014 by Brad Perriello

Biolase CEO Federico Pignatelli is out after a court-ordered shake-up at Biolase.

CEO Pignatelli out in court-ordered shakeup at Biolase

The boardroom and C-suite at Biolase (NSDQ:BIOL) got a shake-up this week following a Delaware Supreme Court decision in a lawsuit filed by Oracle Partners earlier this year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase vows to take another run at Fotona

June 13, 2014 by Brad Perriello

Biolase vows to amend its complaint after a federal judge shoots down its false advertising and defamation claims against rival dental laser maker Fotona.

Biolase vows to take another run at Fotona

A federal judge this month dismissed a Biolase (NSDQ:BIOL) lawsuit alleging false advertising and defamation by dental laser rival Fotona, but left the door open for an amended complaint.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Proxy war brews as activist investor Oracle targets Biolase board

March 17, 2014 by Arezu Sarvestani

Biolase steadies itself against a proxy war filed by activist majority shareholder Oracle Partners over alleged manipulation of the board of directors.

Proxy war brews as activist investor Oracle targets Biolase leadership

Biolase cuts costs ahead of a potential sale, posts losses in Q4

March 11, 2014 by Arezu Sarvestani

Medical lasers maker Biolase is still examining "strategic alternatives" for the company as its slashes about $1.3 million from its payroll and posts continued quarterly losses.

Biolase cuts costs ahead of a potential sale, posts losses in Q4

California medtech company Biolase (NSDQ:BIOL) is looking to slim down ahead of a potential acquisition as the company examines its "strategic alternatives."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Lumenis undercuts IPO price at $12 per share, shares gain nearly 9%

February 27, 2014 by Brad Perriello

Lumenis prices its initial public offering at $12 per share, meaning it will raise about 20% less from the IPO; shares gain nearly 9% in 1st trading.

Lumenis prices IPO at $12 per share, well below range

Lumenis Ltd. today priced its initial public offering at $12 per share, 20% under the low end of the prior $15-$17 range set by the Israeli maker of medical lasers.

Lumenis shares, trading under the "LMNS" symbol on the NASDAQ exchange, opened up 4.2% at $12.50 today and were fetching $13.05 apiece as of about 11:20 a.m., up 8.8%.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp